BDC Capital provides mezz funding to venture-backed Nicoya

May 14, 2019 / Source: The PE Hub Network

BDC Capital has provided undisclosed mezzanine financing to Nicoya Lifesciences Inc, a Kitchener, Ontario-based nanotechnology company.

The funding is part of a $7.7 million investment in Nicoya that is also backed by FedDev Ontario.

BDC invested through its Growth & Transition Capital group. The transaction was led by Director Mark Lunick.

The funds raised will allow Nicoya to develop and market a new version of its flagship product, OpenSPR, a biosensor platform that supports biotechnology and pharmaceutical research applications, and meet demand.

Last year, Nicoya closed a $2 million financing led by Ripple Ventures and Golden Triangle Angel Network. BDC also invested in the round.

Read the full article here.